S&P 500 Buywrite Powershares (PBP) 20.99 $PBP Time for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
S&P 500 Buywrite Powershares (PBP) 20.99 $PBP

Time for Buy Write ETFs?
Sweta Killa - Zacks Investment Research - Mon Feb 08, 9:10AM CST
In a sluggish backdrop, investors are looking to provide capital appreciation opportunities in the equity world with simultaneous downside protection. A gainful option for now could be the Buy-Write strategy.
HSPX: 44.80 (-0.18), QYLD: 22.13 (-0.01), PBP: 20.99 (-0.03), BWV: 67.51 (-0.63), VEGA: 27.29 (+0.06)

Yield Opportunity with a Covered Call ETF Strategy
ETFtrends.com - ETF Trends - Tue Dec 22, 3:30PM CST
With the equities market slowing down after a multi-year rally, investors may find opportunities in exchange traded funds that track buy-write or covered-call strategies. “Many investors overlook buy-write/covered call strategies, as their...
QQQ: 118.33 (-0.76), HSPX: 44.80 (-0.18), QYLD: 22.13 (-0.01), PBP: 20.99 (-0.03)

Utilize a Buy-Write ETF to Generate Yield in a Flat Market
ETFtrends.com - ETF Trends - Mon Aug 17, 1:45PM CDT
In a sideways trending stock market, investors may do well with a buy-write strategy, capitalizing on the attractive yield generation. After a multi-year bull run, the S&P 500 may be winding down. Goldman Sachs even stated that “flat is...
HSPX: 44.80 (-0.18), PBP: 20.99 (-0.03)

BUYINS.NET: ASPS, HIL, PBP, TBNK, UBT, MSG Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri May 22, 6:57AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ALTISOURCE PORTFOLIO SOLUTIONS SA (NASDAQ:ASPS), Hill International Inc (NYSE:HIL), PowerShares S&P 500 BuyWrite Portfolio (NYSEBP), Territorial Bancorp Inc (NASDAQ:TBNK), ProShares Ultra 20+ Year Treasury (NYSE:UBT), The Madison Square Garden Company (NASDAQ:MSG) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
MSG: 171.58 (-1.32), TBNK: 28.85 (-0.06), HIL: 4.47 (-0.07), ASPS: 31.31 (-0.29), UBT: 95.66 (-0.13), PBP: 20.99 (-0.03)

BUYINS.NET: FLM, IPN, JO, KOL, PBP, IHI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Apr 16, 7:17AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Ise Global Engineering And Construction Index Fu (NYSE:FLM), SPDR S&P International Industrial Sector ETF (NYSE:IPN), IPATH DJ-UBS COFFEE SUBINDEX (NYSE:JO), Market Vectors Coal ETF (NYSE:KOL), PowerShares S&P 500 BuyWrite Portfolio (NYSEBP), iShares Dow Jones US Medical Devices Index Fund (NYSE:IHI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
JO: 22.34 (-0.54), FLM: 46.87 (-0.10), KOL: 11.46 (-0.07), IHI: 145.56 (-0.69), PBP: 20.99 (-0.03), IPN: 30.54 (-0.18)

Inside Two New IndexIQ ETFs Designed for Uncertain Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 6:00AM CDT
Two new multi-strategy products from IndexIQ are attempts to ride out the market volatility and offer decent returns.
QLS: 19.24 (-0.15), QAI: 29.32 (-0.04), QED: 20.38 (+0.16), PBP: 20.99 (-0.03)

Options-Based ETFs Generate Better Risk-Adjusted Returns
ETFtrends.com - ETF Trends - Fri Feb 20, 9:30AM CST
Exchange traded funds that employ options have performed as well as the S&P 500 Index with lower volatility, providing investors with higher risk-adjusted returns. “Options-Based Funds had similar returns as the S&P 500 Index with...
FTHI: 20.32 (+0.38), FTLB: 20.03 (-0.09), HSPX: 44.80 (-0.18), HVPW: 19.83 (+0.03), QYLD: 22.13 (-0.01), PBP: 20.99 (-0.03)

Covered Call ETFs to Generate Yield in a Slow-Growth Environment
ETFtrends.com - ETF Trends - Fri Feb 13, 9:00AM CST
Equity investors should temper their expectations as earnings growth could slow this year. If we are in for a more sideways trending market, covered call exchange traded fund strategies could help generate attractive returns. There are a few...
SPY: 215.99 (-1.19), QQQ: 118.33 (-0.76), HSPX: 44.80 (-0.18), QYLD: 22.13 (-0.01), PBP: 20.99 (-0.03)

3 Buy-Write ETFs to Protect Against Market Volatility - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jan 13, 12:00PM CST
A gainful option amid current market turbulence could be the Buy-Write ETFs.
HSPX: 44.80 (-0.18), PBP: 20.99 (-0.03), BWV: 67.51 (-0.63)

Small Percentage of PowerShares ETFs Expected to Distribute Cap Gains
ETFtrends.com - ETF Trends - Mon Dec 15, 8:00AM CST
Further underscoring the tax efficiencies available with exchange traded funds, Invesco’s (NYSE: IVZ) PowerShares unit, the fourth-largest U.S. ETF issuer, said it expects just nine of its 116 ETFs to distribute capital gains this year. As is often...
PHDG: 23.75 (-0.10), PSCH: 76.07 (-0.73), KBWB: 36.65 (-0.04), KBWC: 49.35 (+0.35), PJP: 64.35 (-0.14), KBWP: 50.32 (-0.61), PSCC: 65.59 (-0.31), PBP: 20.99 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading